Therapeutic treatments based on the production of proteins by delivering messenger RNA (mRNA) represent a promising approach. Lipid nanoparticles (LNPs) formed by a cationic ionizable lipid (CIL), DSP
Longitudinal tumor growth metrics (mm³) for xenograft models treated with monotherapies and combinations. Includes individual time points (500–5000 cells) and SDs for replicates (n = 5 mice/group). (X
